Healthy Route Implementation Guide, published by Savannah Informatics. This guide is not an authorized publication; it is the continuous build for version 0.2.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/savannahghi/healthy-route-ig/ and changes regularly. See the Directory of published versions

Table of Contents

0 Table of Contents

1 Home

2 Participant

3 Consent

4 Documents

5 Sites and people

6 Study and participation

7 Visit and measurement

8 Forms and maps

9 Artifacts Summary

9.1 Eligibility checklist, Ghana

9.2 Eligibility checklist, Uganda

9.3 Imaging, Ghana

9.4 Imaging, Uganda

9.5 Laboratory results, Ghana

9.6 Laboratory results, Uganda

9.7 Measure: diet and activity, Uganda (retired)

9.8 Measure: history, Ghana

9.9 Measure: history, Uganda

9.10 Measure: medications, Ghana

9.11 Measure: medications, Uganda

9.12 Measure: vitals, Ghana

9.13 Measure: vitals, Uganda

9.14 Socio-demographics, Ghana

9.15 Healthy Route Blood Pressure

9.16 Healthy Route Consent

9.17 Healthy Route Consent Evidence

9.18 Healthy Route Document

9.19 Healthy Route Investigation Request

9.20 Healthy Route Laboratory Report

9.21 Healthy Route Location

9.22 Healthy Route Measurement

9.23 Healthy Route Organization

9.24 Healthy Route Patient

9.25 Healthy Route Patient (Export)

9.26 Healthy Route Practitioner

9.27 Healthy Route Reported Condition

9.28 Healthy Route Reported Medicine

9.29 Healthy Route Retinal Imaging

9.30 Healthy Route Sample

9.31 Healthy Route Screening Visit

9.32 Healthy Route Study

9.33 Healthy Route Study Participation

9.34 Age in Years

9.35 Reading Device

9.36 Reading Position

9.37 Reading Sequence

9.38 Tenant

9.39 Blood Pressure Monitors Value Set

9.40 Blood Pressure Reading Position Value Set

9.41 Clinic Value Set

9.42 Consent Permission Value Set

9.43 Dose Form Value Set

9.44 Encounter Type Value Set

9.45 Ethnicity, Ghana Value Set

9.46 Eye Value Set

9.47 Frequency Scale Value Set

9.48 Laboratory Units Value Set

9.49 Medicine Frequency Value Set

9.50 Medicine Route Value Set

9.51 Observation Category Value Set

9.52 Physical Activity at Work Value Set

9.53 Reactive or Non-reactive Value Set

9.54 Type of Domicile Value Set

9.55 Urine Dipstick Protein Value Set

9.56 Use Status Value Set

9.57 Blood Pressure Monitors

9.58 Blood Pressure Reading Position

9.59 Clinic

9.60 Consent Permission

9.61 Dose Form

9.62 Encounter Type

9.63 Ethnicity, Ghana

9.64 Eye

9.65 Frequency Scale

9.66 Healthy Route Measurement Codes

9.67 Medicine Frequency

9.68 Medicine Route

9.69 Observation Category

9.70 Physical Activity at Work

9.71 Reactive or Non-reactive

9.72 Sign-off

9.73 Type of Domicile

9.74 Urine Dipstick Protein Scale

9.75 Use Status

9.76 Extract the diet and activity form (retired)

9.77 Extract the eligibility checklist

9.78 Extract the history form

9.79 Extract the imaging form

9.80 Extract the laboratory results form

9.81 Extract the medications form

9.82 Extract the socio-demographics form

9.83 Extract the vitals form

9.84 Blood pressure, derived value

9.85 Blood pressure, first reading

9.86 Blood pressure, second reading

9.87 Blood pressure, third reading

9.88 Blood sample

9.89 eGFR by CKD-EPI 2021

9.90 Example consent to study participation

9.91 Example general out-patient clinic

9.92 Example participant

9.93 Example participation ending in screen failure

9.94 Example renal clinic

9.95 Example response: diet and activity

9.96 Example response: eligibility

9.97 Example response: eligibility, Ghana

9.98 Example response: history

9.99 Example response: history, Ghana

9.100 Example response: imaging

9.101 Example response: imaging

9.102 Example response: imaging, Ghana

9.103 Example response: laboratory results

9.104 Example response: laboratory results, Ghana

9.105 Example response: medications

9.106 Example response: medications

9.107 Example response: medications, Ghana

9.108 Example response: socio-demographics, Ghana

9.109 Example response: vitals

9.110 Example response: vitals, Ghana

9.111 Example screening visit

9.112 Example study site

9.113 Example study team member

9.114 Example study, country A

9.115 Example study, country B

9.116 HbA1c

9.117 History: diabetes, as reported

9.118 History: tobacco smoking status

9.119 Laboratory report

9.120 Reported condition: diabetes

9.121 Reported medicine: amlodipine

9.122 Request for laboratory investigations

9.123 Retinal photography, both eyes

9.124 Serum creatinine

9.125 Urine albumin-to-creatinine ratio

9.126 Urine dipstick protein

9.127 Urine sample